Astragaloside IV as a promising therapeutic agent for liver diseases: current landscape and future perspectives
Astragaloside IV (C41H68O14, AS-IV) is a naturally occurring saponin isolated from the root of Astragalus membranaceus, a widely used traditional Chinese botanical drug in medicine. In recent years, AS-IV has attracted considerable attention for its hepatoprotective properties, which are attributed...
Saved in:
| Main Authors: | Chunyan Chen, Xiaolan Bu, Liping Deng, Jiayan Xia, Xinming Wang, Li Chen, Wen Li, Jie Huang, Qixiang Chen, Cheng Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1574154/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apigenin as an emerging hepatoprotective agent: current status and future perspectives
by: Cheng Wang, et al.
Published: (2024-12-01) -
Astragaloside IV: a potential nemesis for gastric cancer
by: Chao Hu, et al.
Published: (2025-07-01) -
Astragaloside IV alleviated bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and fecal metabolism
by: Huichao Wang, et al.
Published: (2025-04-01) -
Astragaloside IV represses hepatocellular carcinoma progression by modulating HMGB1-ferroptosis axis
by: Xingyang Zhao, et al.
Published: (2025-08-01) -
Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol
by: Bei-Bei Xiong, et al.
Published: (2025-05-01)